pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital clinical programs — 1136 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
First People's Hospital projects
1,136 ClinicalTrials.gov programs sponsored by First People's Hospital.
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Peak value anti-Xa
The First People's Hospital of Lianyungang
Venous Thromboembolism
1 trial -
Peginterferon α-2b injection
The First People's Hospital of Lianyungang
Condylomata Acuminata
1 trial -
Peginterferon α-2b plus an anti-PD-1
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
Personalized mRNA Tumor Vaccine
The First People's Hospital of Lianyungang
Esophageal Cancer
1 trial -
Prebiotic Fiber Supplement + loperamide hydrochloride capsule
The First People's Hospital of Lianyungang
Chemotherapy-related Diarrhea
1 trial -
Prediction Model Arm
The First People's Hospital of Lianyungang
Lung Cancer Screening
1 trial -
Prediction of intraoperative hypothermia risk
The First People's Hospital of Lianyungang
Intraoperative Hypothermia
1 trial -
Prednisolone
The First People's Hospital of Lianyungang
HIV (Human Immunodeficiency Virus)
1 trial -
Prostate biopsy guided by PSMA PET/CT
The First People's Hospital of Lianyungang
PSMA PET/CT
1 trial -
Protocol-based management of perioperative antithrombotic therapy
The First People's Hospital of Lianyungang
Antithrombotic Therapy
1 trial -
Pueraria lobata radix
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
R-CDOP
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
RB001
The First People's Hospital of Lianyungang
Phelan-McDermid Syndrome
1 trial -
Regional lymph node radiotherapy (RNI) including the axilla
The First People's Hospital of Lianyungang
Axillary Lymph Node Dissection
1 trial -
Regorafenib and Sintilimab in combination with electroacupuncture
The First People's Hospital of Lianyungang
Colorectal Cancer Metastatic
1 trial -
Remimazolam
The First People's Hospital of Lianyungang
Sedation and Analgesia
1 trial -
Remimazolam Tosilate
The First People's Hospital of Lianyungang
Frailty
1 trial -
Remimazolam besylate
The First People's Hospital of Lianyungang
Remimazolam
1 trial -
Respiratory monitoring
The First People's Hospital of Lianyungang
Post-Op Complication
1 trial -
Rifaximin
The First People's Hospital of Lianyungang
Bacterial Overgrowth Syndrome Small Bowel
1 trial -
Romiplostim N01
The First People's Hospital of Lianyungang
Primacy Immune Thrombocytopenia
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Surgery
1 trial -
Routine Medication
The First People's Hospital of Lianyungang
Generalized Anxiety Disorder
1 trial -
Ruxolitinib+Calcineurin inhibitor+Methotrexate
The First People's Hospital of Lianyungang
Graft Versus Host Disease
1 trial -
S-ketamine
The First People's Hospital of Lianyungang
Opioid Use, Unspecified
1 trial -
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
The First People's Hospital of Lianyungang
SARS-CoV-2
1 trial -
SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
The First People's Hospital of Lianyungang
SARS-CoV-2
1 trial -
SHAPE
The First People's Hospital of Lianyungang
Liver Cirrhosis
1 trial -
SLE group
The First People's Hospital of Lianyungang
Lupus Nephritis
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
SSRI
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
SSRIs
The First People's Hospital of Lianyungang
Major Depressive Disorder
2 trials -
Secukinumab 300 MG; Tofacitinib 11mg
The First People's Hospital of Lianyungang
Hidradenitis Suppurativa
1 trial -
Selective Serotonin Reuptake Inhibitors (SSRIs)
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Aged
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Anesthesia, General
1 trial -
Shenbai Granules
The First People's Hospital of Lianyungang
Colorectal Adenoma
1 trial -
Sildenafil 100 MG
The First People's Hospital of Lianyungang
Central Venous Pressure
1 trial -
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Sivelestat sodium
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Snap
The First People's Hospital of Lianyungang
Arrhythmia
1 trial -
Sodium Bicarbonate Ringer's Solution
The First People's Hospital of Lianyungang
Hyperlactacidemia
1 trial
Frequently asked questions
How many clinical projects does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.